ReviewBlood and lymphatic cancer : targets and therapy2018

Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives.

Theodora Anagnostou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.